These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21119250)

  • 1. Estimation and comparative study of serum total sialic acid levels as tumor markers in oral cancer and precancer.
    Joshi M; Patil R
    J Cancer Res Ther; 2010; 6(3):263-6. PubMed ID: 21119250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer.
    Sawhney H; Kumar CA
    Cancer Biomark; 2011-2012; 10(1):43-9. PubMed ID: 22297551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
    Rajpura KB; Patel PS; Chawda JG; Shah RM
    J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
    Ghosh M; Nayak BR
    Ann Dent; 1991; 50(2):33-5, 48. PubMed ID: 1785913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels in serum of total sialic acid, lipid-associated sialic acid, and fucose in precancerous lesion and cancer of the oral cavity.
    Rao VR; Krishnamoorthy L; Kumaraswamy SV; Ramaswamy G
    Cancer Detect Prev; 1998; 22(3):237-40. PubMed ID: 9618045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of serum fucose and serum sialic acid levels in oral squamous cell carcinomia.
    Shashikanth MC; Rao BB
    Indian J Dent Res; 1994; 5(4):119-24. PubMed ID: 9495093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse.
    Chole RH; Patil RN; Basak A; Palandurkar K; Bhowate R
    J Cancer Res Ther; 2010; 6(4):487-91. PubMed ID: 21358086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer.
    Raval GN; Patel DD; Parekh LJ; Patel JB; Shah MH; Patel PS
    Oral Dis; 2003 May; 9(3):119-28. PubMed ID: 12945593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of glycoproteins as prognosticators in head and neck malignancy.
    Bathi RJ; Nandimath K; Kannan N; Shetty P
    Indian J Dent Res; 2001; 12(2):93-9. PubMed ID: 11665403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum and salivary total sialic acid and α-l-fucosidase in patients with oral precancerous conditions and oral cancer.
    Vajaria BN; Patel KR; Begum R; Shah FD; Patel JB; Shukla SN; Patel PS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jun; 115(6):764-71. PubMed ID: 23570662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of correlation of serum lipid profile in patients with oral cancer and precancer and its association with tobacco abuse.
    Lohe VK; Degwekar SS; Bhowate RR; Kadu RP; Dangore SB
    J Oral Pathol Med; 2010 Feb; 39(2):141-8. PubMed ID: 20002982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of total and lipid-bound sialic acid in malignancies].
    Cylwik B; Chrostek L; Szmitkowski M
    Pol Merkur Lekarski; 2005 Aug; 19(110):237-41. PubMed ID: 16245443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
    Shah M; Telang S; Raval G; Shah P; Patel PS
    Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for oral precancer with noninvasive genetic cytology.
    Bremmer JF; Graveland AP; Brink A; Braakhuis BJ; Kuik DJ; Leemans CR; Bloemena E; van der Waal I; Brakenhoff RH
    Cancer Prev Res (Phila); 2009 Feb; 2(2):128-33. PubMed ID: 19174582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total and lipid-bound serum sialic acid in children with malignancy or infections.
    Romppanen J; Petäjä J; Heikinheimo M; Mononen I
    Anticancer Res; 1998; 18(4B):2793-7. PubMed ID: 9713463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.
    Ralhan R; Nath N; Agarwal S; Mathur M; Wasylyk B; Shukla NK
    Clin Cancer Res; 1998 Sep; 4(9):2147-52. PubMed ID: 9748133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum anti-p53 antibodies as a diagnostic tumor marker: observations in patients with malignant and premalignant oral cavity lesions.
    Porrini R; Vercellino V; Rocchetti V; Renò F; Giorda E; Pomato E; Cannas M; Sabbatini M
    Minerva Stomatol; 2010 May; 59(5):233-9, 239-43. PubMed ID: 20502428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sialic acid in patients with multiple myeloma.
    Crook MA; Couchman S; Tutt P
    Br J Biomed Sci; 1996 Sep; 53(3):185-6. PubMed ID: 8914343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [N-acetylneuraminic acid (sialic acid) as a tumor marker in head and neck cancers].
    Fischer F; Egg G
    HNO; 1990 Oct; 38(10):361-3. PubMed ID: 2283329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Level of sialic acid in blood serum as a tumor marker].
    Paszkowska A; Berbeć H; Cybulski M
    Przegl Lek; 1997; 54(12):851-3. PubMed ID: 9591453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.